Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2022 Financial Results on February 7, 2023

Rhea-AI Summary

Inspire Medical Systems, Inc. (NYSE: INSP) will release its financial results for Q4 and fiscal 2022 on February 7, 2023, after market close. A conference call will follow at 5:00 p.m. ET to discuss the results and business updates. Investors can access the call through the company's Investor Relations page. Inspire specializes in innovative treatments for obstructive sleep apnea, with its Inspire therapy being the first FDA-approved neurostimulation technology for moderate to severe cases. Further details will be available on the company's website.

Positive

• Inspire therapy is the first FDA-approved neurostimulation technology for obstructive sleep apnea.

Negative

• None.

MINNEAPOLIS, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and fiscal 2022 after the close of trading on Tuesday, February 7. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q4 2022 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Inspire's Q4 2022 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call. 

Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443

FAQ

When will Inspire Medical Systems release its Q4 2022 financial results?

Inspire Medical Systems will release its Q4 2022 financial results on February 7, 2023.

What time is the Inspire Medical Systems conference call?

The conference call will be held at 5:00 p.m. ET on February 7, 2023.

How can I access the Inspire Medical Systems earnings call?

You can access the earnings call via the Investor Relations page on Inspire's website.

What is the focus of Inspire Medical Systems?

Inspire Medical Systems focuses on developing innovative treatments for obstructive sleep apnea.